Although IFITM3 had been reported to engage in different regulatory signaling pathways to exert oncogenic functions in several other cancer types, IFITM3 was only suggested to be a potential target of the Wnt/β-catenin signaling in gastric cancer [50]. The gene discussed is IFITM3; the disease is cancer.